Iwaszko, M.; Åšwierkot, J.; Kolossa, K.; Jeka, S.; Wiland, P.; Bogunia-Kubik, K.
Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes 2018, 9, 94.
https://doi.org/10.3390/genes9020094
AMA Style
Iwaszko M, Åšwierkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K.
Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes. 2018; 9(2):94.
https://doi.org/10.3390/genes9020094
Chicago/Turabian Style
Iwaszko, Milena, Jerzy Åšwierkot, Katarzyna Kolossa, SÅ‚awomir Jeka, Piotr Wiland, and Katarzyna Bogunia-Kubik.
2018. "Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64" Genes 9, no. 2: 94.
https://doi.org/10.3390/genes9020094
APA Style
Iwaszko, M., Åšwierkot, J., Kolossa, K., Jeka, S., Wiland, P., & Bogunia-Kubik, K.
(2018). Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64. Genes, 9(2), 94.
https://doi.org/10.3390/genes9020094